# W. R. Berkley Corporation (WRB) financials

W. R. Berkley Corporation reported revenue of $14.7 billion for fiscal year 2025 (the twelve months to 31 Dec 2025), up 7.8% from fiscal 2024. Net income was $1.78 billion and diluted earnings per share $4.45.

In its latest reported quarter, the third quarter of fiscal 2026 (the three months to 30 Sep 2026), revenue was $3.74 billion, down 0.8% from a year earlier.

Source: W. R. Berkley Corporation's annual and quarterly reports, compiled and checked by AapWire. Latest report filed 2 Nov 2026. Amounts in USD. Page: https://aapwire.com/stocks/WRB. Retrieved 2026-11-16.

## Latest results: Q3 FY2026

W. R. Berkley Corporation reported revenue of $3.74 billion, down 0.8% from a year earlier, net income of $446 million and diluted earnings per share of $1.14 against $1.28 for the third quarter of fiscal 2026 (the three months to 30 Sep 2026).

From its quarterly report, filed 2 Nov 2026.

| Measure | Q3 FY2026 | Q3 FY2025 | Change |
| --- | ---: | ---: | ---: |
| Revenue | $3.74B | $3.77B | −0.8% |
| Net income | $446.0M | $511.0M | −12.7% |
| Diluted EPS | $1.14 | $1.28 | −10.9% |
| Operating cash flow | $731.3M | $1.14B | −35.8% |
| Capital expenditure | $10.20M | $16.94M | −39.8% |
| Free cash flow | $721.1M | $1.12B | −35.8% |

Page: https://aapwire.com/stocks/WRB/earnings

## Annual figures (fiscal years)

| Measure | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $7.65B | $7.68B | $7.69B | $7.90B | $8.10B | $9.46B | $11.17B | $12.14B | $13.64B | $14.71B |
| Revenue growth | +6.2% | +0.4% | +0.1% | +2.7% | +2.5% | +16.7% | +18.1% | +8.7% | +12.3% | +7.8% |
| Net income | $601.9M | $549.1M | $640.7M | $681.9M | $530.7M | $1.02B | $1.38B | $1.38B | $1.76B | $1.78B |
| Diluted EPS | $1.39 | $1.26 | $1.48 | $1.57 | $1.25 | $2.44 | $3.29 | $3.37 | $4.36 | $4.45 |
| Operating cash flow | $848.4M | $710.9M | $620.2M | $1.14B | $1.62B | $2.18B | $2.57B | $2.93B | $3.68B | $3.58B |
| Capital expenditure | $50.83M | $115.7M | $49.86M | $60.46M | — | — | — | — | — | — |
| Free cash flow | $797.5M | $595.2M | $570.3M | $1.08B | — | — | — | — | — | — |
| Net margin | 7.9% | 7.1% | 8.3% | 8.6% | 6.6% | 10.8% | 12.4% | 11.4% | 12.9% | 12.1% |
| Cash and equivalents | $795.3M | $950.5M | $817.6M | $1.02B | $2.37B | $1.57B | $1.45B | $1.36B | $1.97B | $2.54B |
| Total debt | $2.49B | $2.50B | $2.79B | $2.86B | $2.93B | $3.48B | $3.04B | $3.06B | $3.06B | $3.81B |
| Shareholders' equity | $5.05B | $5.41B | $5.44B | $6.07B | $6.31B | $6.65B | $6.75B | $7.46B | $8.40B | $9.70B |
| Diluted shares | 434M | 435M | 433M | 435M | 425M | 420M | 419M | 410M | 403M | 400M |
| Dividends per share | — | $0.46 | $0.62 | $0.75 | $0.21 | $0.89 | $0.59 | $1.29 | $1.40 | $1.85 |

## Quarterly figures (last eight fiscal quarters)

| Measure | Q4 FY2024 | Q1 FY2025 | Q2 FY2025 | Q3 FY2025 | Q4 FY2025 | Q1 FY2026 | Q2 FY2026 | Q3 FY2026 |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $3.67B | $3.55B | $3.67B | $3.77B | $3.72B | $3.69B | $3.72B | $3.74B |
| Revenue, year on year | +13.9% | +8.9% | +10.8% | +10.8% | +1.5% | +4.0% | +1.2% | −0.8% |
| Net income | $576.1M | $417.6M | $401.3M | $511.0M | $449.5M | $515.2M | $452.3M | $446.0M |
| Diluted EPS | $1.44 | $1.04 | $1.00 | $1.28 | $1.13 | $1.31 | $1.15 | $1.14 |
| Free cash flow | — | $727.6M | $683.2M | $1.12B | — | $640.2M | $784.2M | $721.1M |

## Operating KPIs

| KPI | Latest | Period | Change on a year |
| --- | ---: | --- | --- |
| [Gross premiums written](https://aapwire.com/stocks/WRB/kpi/gross-premiums-written) | $4.0B | quarter to 30 Sep 2026 | up 3.0% |
| [Net premiums written](https://aapwire.com/stocks/WRB/kpi/net-premiums-written) | $3.3B | quarter to 30 Sep 2026 | up 1.3% |
| [Business, Insurance gross premiums written](https://aapwire.com/stocks/WRB/kpi/business-insurance-gross-premiums-written) | $3.6M | quarter to 30 Sep 2026 | up 4.9% |
| [Business, Insurance net premiums written](https://aapwire.com/stocks/WRB/kpi/business-insurance-net-premiums-written) | $2.9M | quarter to 30 Sep 2026 | up 3.2% |
| [Business, Insurance loss ratio](https://aapwire.com/stocks/WRB/kpi/business-insurance-loss-ratio) | 63.3% | quarter to 30 Sep 2026 | down 0.6 points |
| [Business, Insurance GAAP Combined ratio](https://aapwire.com/stocks/WRB/kpi/business-insurance-gaap-combined-ratio) | 91.7% | quarter to 30 Sep 2026 | down 0.6 points |
| [Gross premiums written (Business, Reinsurance & Monoline Excess)](https://aapwire.com/stocks/WRB/kpi/gross-premiums-written-business-reinsurance-and-monoline-excess) | $391,479 | quarter to 30 Sep 2026 | down 11.7% |
| [Net premiums written (Business, Reinsurance & Monoline Excess)](https://aapwire.com/stocks/WRB/kpi/net-premiums-written-business-reinsurance-and-monoline-excess) | $368,586 | quarter to 30 Sep 2026 | down 11.6% |
| [Loss ratio (Business, Reinsurance & Monoline Excess)](https://aapwire.com/stocks/WRB/kpi/loss-ratio-business-reinsurance-and-monoline-excess) | 53.2% | quarter to 30 Sep 2026 | up 1.9 points |
| [GAAP Combined ratio (Business, Reinsurance & Monoline Excess)](https://aapwire.com/stocks/WRB/kpi/gaap-combined-ratio-business-reinsurance-and-monoline-excess) | 83.4% | quarter to 30 Sep 2026 | up 2.3 points |
| [Business loss ratio](https://aapwire.com/stocks/WRB/kpi/business-loss-ratio) | 62.2% | quarter to 30 Sep 2026 | down 0.2 points |
| [Business GAAP Combined ratio](https://aapwire.com/stocks/WRB/kpi/business-gaap-combined-ratio) | 90.8% | quarter to 30 Sep 2026 | down 0.1 points |
| [Insurance short-tail lines](https://aapwire.com/stocks/WRB/kpi/insurance-short-tail-lines) | 670.3M lines | at 30 Sep 2026 | up 5.3% |
| [Arbitrage trading account (full year)](https://aapwire.com/stocks/WRB/kpi/arbitrage-trading-account-full-year) | 10,313 | at 31 Mar 2026 | down 36.8% |
| [Insurance revenue](https://aapwire.com/stocks/WRB/kpi/insurance-revenue) | $3.2B | quarter to 30 Sep 2026 | up 3.8% |
| [Reinsurance & Monoline Excess revenue](https://aapwire.com/stocks/WRB/kpi/reinsurance-and-monoline-excess-revenue) | $426.6M | quarter to 30 Sep 2026 | down 6.2% |

## Method

Each period is read from the report the company filed and checked against accounting identities; a figure that does not pass is left blank (—), never estimated. Free cash flow is operating cash flow less capital expenditure. Diluted EPS is as the company reported it, adjusted for later stock splits. Research information only, not investment advice.
